A Randomized Phase III Study Evaluating Pegylated Liposomal Doxorubicin Versus Capecitabine As First-line Therapy For Metastatic Breast Cancer: Results Of The PELICAN Study
Nadia Harbeck, , Steffen Saupe, Elke Jäger, Marcus Schmidt, Rolf Kreienberg, Lothar Müller, Burkhard Joerg Otremba, Dirk Waldenmaier, Julia Dorn, Mathias Warm, Michael Scholz, Michael Untch, Maike de Wit, Jana Barinoff, Hans-Joachim Lück, Philipp Harter, Doris Augustin, Paul Harnett, Matthias W. Beckmann, Salah-Eddin Al-Batran
Twitter
Facebook
LinkedIn
Email